Welltower Inc. (WELL) is a leading real estate investment trust (REIT) that specializes in providing capital to senior housing operators, post-acute care providers, and health systems. Established in 1970, the company's headquarters is in Toledo, Ohio. It’s involved in investments spanning the full spectrum of health-related real estate, from senior living communities to medical office buildings and outpatient medical centers.
Welltower operates on a platform of investing in strategic partnerships with innovative senior living and health care providers, aiming to improve the healthcare infrastructure and better the living conditions of elders. With an asset portfolio of more than $30 billion, Welltower is currently the largest publicly traded REIT in the U.S. focused on health care and senior housing.
The company's business model is focused on understanding the health care delivery in the markets it serves in order to recognize real estate investment opportunities. Welltower aims to transform healthcare delivery by investing in leading healthcare systems, biotechs, and post-acute providers to improve people’s wellness and the quality of their lives.
The company has a diverse portfolio of properties in targeted, high-growth markets. As of now, they boast more than 1,300 properties located in the U.S., the United Kingdom, and Canada. These properties encompass senior housing communities, outpatient medical properties, hospitals, memory care facilities, assisted living facilities, and post-acute care facilities.
Welltower's long-term strategy focuses on making investments that are designed to yield predictable returns and provide steady growth. They operate on a triple-net lease structure, which allows them to generate stable revenues as their operators absorb the majority of the operational costs. This strategy has allowed the company to consistently provide dividends to its shareholders.
The company is publicly traded on the New York Stock Exchange under the ticker symbol WELL. It’s named as one of Fortune's World's Most Admired Real Estate Companies and is committed to sustainable business practices. Welltower also leads the sector in ESG (Environmental, Social, and Governance) performance and has been widely recognized for its corporate responsibility efforts.
Welltower Inc. continues to focus on investing in and transforming the health care infrastructure to provide high-quality living for older adults, thereby addressing the rising demand for health care facilities and services. As an industry leader, Welltower is in a position to significantly impact the future of healthcare real estate and create sustainable value for its partners, communities, and shareholders.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Welltower Inc. recently acquired three nursing homes in Broward County, Florida, from TL Management for $160 million, bringing its total nursing home transactions in the region to nine. This latest acquisition, combined with previous deals, totals $386 million for nine Florida nursing homes. Key properties acquired include the 294-bed Unity Health and Rehabilitation Center in Miami for $74.3 million and the 120-bed Palms Care Center and Rehab in Lauderdale Lakes for $45 million.
The iShares Core U.S. REIT ETF (NYSEARCA:USRT) offers broad exposure to 122 U.S. real estate investment trusts across various property types, including healthcare, industrial, data centers, residential, and retail. With net assets of approximately $4.3 billion and an expense ratio of 0.08%, its largest holdings include Welltower, Prologis, and Equinix. The fund distributes income quarterly, with results influenced by interest rates, leasing demand, and the financial health of its underlying property companies.
UBS Group has raised its price target for Welltower (NYSE:WELL) from $269.00 to $289.00, maintaining a "buy" rating and suggesting a potential upside of nearly 17%. This comes after Welltower reported strong quarterly earnings, beating consensus estimates for both EPS and revenue. The real estate investment trust currently holds a "Moderate Buy" consensus rating among analysts with an average price target of $263.10.
UBS Group has increased its price target for Ventas (NYSE:VTR) from $90.00 to $99.00, maintaining a "neutral" rating, indicating a potential upside of 9.56%. Other analysts have also adjusted their price targets, resulting in a "Moderate Buy" consensus rating and an average target price of $99.68 for the real estate investment trust. Despite missing EPS estimates, Ventas reported a 23% year-over-year revenue increase to $1.83 billion, exceeding expectations.
Bahl & Gaynor LLC significantly increased its stake in Welltower Inc. (NYSE:WELL) by 211.6% in the third quarter, acquiring an additional 214,997 shares, bringing its total holdings to 316,619 shares valued at approximately $72.9 million. This increase follows Welltower's strong third-quarter earnings, where it surpassed analyst expectations with an EPS of $1.67 and a revenue increase of 38.4% year-over-year. Insider buying by Director Andrew Gundlach and a "Moderate Buy" consensus rating from analysts with an average price target of $262.14 further highlight positive sentiment around the real estate investment trust.
Brookdale Senior Living has revised its financial forecasts for the fourth quarter and full year due to slower-than-expected occupancy growth in Q3. The company's CEO, Nick Stengle, stated that while Q3 adjusted EBITDA met expectations, RevPAR growth fell short, leading to new sales and marketing strategies focused on increasing internal lead generation. Despite these challenges, Brookdale aims for mid-teens annual adjusted EBITDA growth in 2027 and beyond and continues its portfolio optimization efforts.
Pictet Asset Management Holding SA reduced its stake in Welltower Inc. by 5.8% in the third quarter, selling 55,039 shares and holding 890,406 shares valued at $205 million. Despite the institutional selling, Welltower reported strong quarterly earnings of $1.67 EPS, beating estimates, with revenue rising 38.4% year-over-year to $3.72 billion. The company also announced a quarterly dividend of $0.85 per share and maintains a "Moderate Buy" consensus rating from analysts.